Biotech Stocks Newsletter – April 27, 2018

0
730

More Industry Vets Coming Onboard!

It looks like the market activity for GTBP is starting to really pick up and this could be a clear indicator that biotech investors are beginning to take notice! This up-and-coming biotech company has a therapy pipeline that has attracted some of the industry’s most experienced leaders. Now it looks like other outlets have started to look to GTBP for new market potential.

SEE FOR YOURSELF CLICK HERE!


Seasoned Financial Executive Federica O’Brien Joins GT Biopharma’s (GTBP) Board of Directors

GT Biopharma Inc. (OTCQB: GTBP), an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary platforms, today announced the addition of Federica O’Brien, CPA to GT Biopharma’s board of directors effective immediately. Ms. O’Brien is expected to chair the Company’s audit committee.

SEE FOR YOURSELF CLICK HERE!


Disclaimer: Biotechstocks.com is owned by – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $1,800,000.00 by a GT Biopharma Inc. for a period beginning August 1, 2017 and ending April. 30, 2018 to publicly disseminate information about (GTBP). We own zero shares. Biotechstocks.com is owned by – MIDAM VENTURES LLC., a Florida Corporation that has been compensated $200,000.00 by a GT Biopharma Inc. for a period beginning May 1, 2018 and ending May. 31, 2018 to publicly disseminate information about (GTBP). We own zero shares. Full Disclaimer Here

LEAVE A REPLY

Please enter your comment!
Please enter your name here